Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02265718 · ClinicalTrials.gov registry record

A Study To Evaluate The Difference In iPad-Based Cognitive Video Game (Akili Interactive's Project: EVO) Performance In Amyloid-Positive Versus Amyloid-Negative Healthy Elderly Volunteers

A clinical trial of Healthy, sponsored by Pfizer.

Completed
Registry status
97
Enrollment target
4
Study locations

NCT02265718 is a study of Healthy that has completed, run by Pfizer. The registered enrollment target is 97 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (85% lower). The trial reports 4 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02265718, a study of Healthy, has completed, sponsored by Pfizer.

COMPLETED
Registry status
97 participants
Enrollment target
4
Study locations

Study Summary

The purpose of the study is to evaluate the difference in learning and performance measures associated with repeated use of an iPad video game (Akili Interactive's Project: EVO) in healthy elderly volunteers based on amyloid status.

Conditions Studied

Interventions

  • DRUG Placebo
  • DRUG Ritalin

Study Locations (4)

Florida

  • Broward Research Group - Hollywood
  • Miami Research Associates - South Miami

California

  • Collaborative Neuroscience Network, LLC - Long Beach

Michigan

  • Jasper Clinic, Inc. - Kalamazoo

Trial Details

FieldValue
Enrollment Target 97 participants
Start Date 2014-09
Est. Completion 2016-05

Sponsor

Pfizer

1,845 total trials

What the Registry Record Tells You About NCT02265718

The ClinicalTrials.gov registry entry for NCT02265718 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 97 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (85% lower). The listed sponsor is Pfizer, which has 1,845 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Healthy appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT02265718 reports 4 study locations spanning 3 distinct geographic areas - top geographies include Florida, California, Michigan.

Frequently Asked Questions

What is clinical trial NCT02265718 about?

NCT02265718 is a clinical study titled "A Study To Evaluate The Difference In iPad-Based Cognitive Video Game (Akili Interactive's Project: EVO) Performance In Amyloid-Positive Versus Amyloid-Negative Healthy Elderly Volunteers". The purpose of the study is to evaluate the difference in learning and performance measures associated with repeated use of an iPad video game (Akili Interactive's Project: EVO) in healthy elderly volunteers based on amyloid status.

What is the current status of trial NCT02265718?

This trial is currently completed. The enrollment target is 97 participants. The study started on 2014-09. Estimated completion is 2016-05.

What conditions does trial NCT02265718 study?

This clinical trial studies the following conditions: Healthy.

What interventions are being tested in trial NCT02265718?

The interventions under investigation include: Placebo (DRUG), Ritalin (DRUG).

Who is sponsoring clinical trial NCT02265718?

This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02265718 being conducted?

This trial has 4 study locations across California, Florida, Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Healthy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.